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ABSTRACT
Background Helicobacter pylori-induced peptic
ulceration is less likely to occur in patients with a strong
gastric anti-inﬂammatory regulatory T cell (Treg)
response. Migration of Tregs into the gastric mucosa is
therefore important.
Objective To identify the homing receptors involved in
directing Tregs to the gastric mucosa, and investigate
how H pylori stimulates the relevant chemokine
responses.
Design Gastric biopsy samples and peripheral blood
were donated by 84 H pylori-infected and 46 uninfected
patients. Luminex assays quantiﬁed gastric biopsy
chemokine concentrations. Flow cytometry was used to
characterise homing receptors on CD4+CD25hi Tregs.
H pylori wild-type and isogenic mutants were used to
investigate the signalling mechanisms behind CCL20 and
IL-8 induction in gastric epithelial cell lines. Transwell
assays were used to quantify Treg migration towards
chemokines in vitro.
Results CCL20, CXCL1-3 and IL-8 concentrations were
signiﬁcantly increased in gastric biopsy samples from
H pylori-infected patients. CCR6 (CCL20 receptor),
CXCR1 and CXCR2 (IL-8 and CXCL1-3 receptors) were
expressed by a higher proportion of peripheral blood
Tregs in infected patients. Most gastric Tregs expressed
these receptors. H pylori induced CCL20 production by
gastric epithelial cells via cag pathogenicity island
(cagPAI)-dependent NF-κB signalling. Foxp3+, but not
Foxp3−, CD4 cells from infected mice migrated towards
recombinant CCL20 in vitro.
Conclusions As well as increasing Treg numbers,
H pylori infection induces a change in their
characteristics. Expression of CCR6, CXCR1 and CXCR2
probably enables their migration towards CCL20 and IL-
8 in the infected gastric mucosa. Such qualitative
changes may also explain how H pylori protects against
some extragastric inﬂammatory disorders.
INTRODUCTION
Helicobacter pylori colonises the stomach in
around half of the world’s population.1 In most
cases the infection is established during child-
hood and persists lifelong.2 This chronic infec-
tion leads to continuous low-level gastric
inﬂammation, which is asymptomatic in most
cases. However, some people develop more pro-
nounced inﬂammation, which can lead to peptic
ulcer disease (PUD) or gastric cancer.3 By under-
standing the factors which inﬂuence the
inﬂammatory response to H pylori and gastric
inﬁltration of immune cells, we may be able to
identify those who are at increased risk of devel-
oping disease.
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Signiﬁcance of this study
What is already known about this subject?
▸ Helicobacter pylori infection is the major cause
of peptic ulcer disease and gastric
adenocarcinoma.
▸ Individuals infected with H pylori have
increased populations of immunosuppressive
regulatory T cells (Tregs) in their gastric
mucosa.
▸ Those with an insufﬁcient Treg response tend
to have greater levels of inﬂammation in the
gastric mucosa, and are more likely to develop
peptic ulcer disease.
What are the new ﬁndings?
▸ The concentration of the chemokine CCL20 is
dramatically increased in the gastric mucosa of
patients infected by H pylori and the vast
majority of mucosal Tregs express its receptor
CCR6.
▸ Gastric biopsy samples from patients infected
with cag+ strains contain higher concentrations
of CCL20. CCL20 expression is induced in
gastric epithelial cells in a cag type IV secretion
system dependent manner.
▸ Recombinant CCL20 induces the migration of
Tregs in vitro, demonstrating its importance as
a chemoattractant for these cells.
▸ Homing receptor proﬁles of circulating Tregs
differ between infected and uninfected
patients. H pylori therefore imparts qualitative
differences to these populations.
How might it impact on clinical practice in
the foreseeable future?
▸ This work indicates the importance of the
CCL20–CCR6 axis in the recruitment of Tregs to
the gastric mucosa. As this axis is also
important in IBD, the study might contribute to
the development of new treatments to suppress
gastrointestinal inﬂammation.
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Proinﬂammatory chemokines and cytokines, such as interleu-
kin 8 (IL-8), are secreted by gastric epithelial cells in response to
H pylori infection, leading to immune cell recruitment.2
H pylori expresses virulence determinants, including the poly-
morphic vacuolating cytotoxin gene A (vacA) and the cag patho-
genicity island (cagPAI), which inﬂuence disease risk.1 The
cagPAI encodes a type IV secretion system (T4SS), which deli-
vers the effector protein CagA and soluble bacterial cell wall
components into host cells.4 Inﬂammatory signalling pathways
are activated directly by CagA or through NOD1-recognition of
cell wall components.5 6 The resulting cytokine production
leads to increased mucosal inﬁltration of neutrophils, macro-
phages and proinﬂammatory T-helper subsets including Th1
and Th17 cells and an increased risk of PUD.5 7
One of the major modulators of inﬂammation is the subset of
CD4 T cells known as regulatory T cells (Tregs). These cells sup-
press both innate and adaptive immune responses, and inhibit
the activity of T-helper cells.8 Previously we showed that
CD4+CD25hi cells are more abundant in the gastric mucosa of
H pylori-infected patients, and that poor Treg responses are asso-
ciated with PUD.9 Recruitment of Tregs to the gastric mucosa is
important for controlling inﬂammation and pathology.9–12
We previously found that Tregs are also more abundant in the
peripheral blood of H pylori-infected patients.13 This popula-
tion of Tregs appears to have slightly different characteristics
from those found in the gastric mucosa, in that not all periph-
eral blood CD4+CD25hi cells express FOXP3. We hypothesised
that some peripheral blood Treg populations in infected patients
are programmed for homing to the inﬂamed gastric mucosa.
The chemokines CCL2, CCL4, CCL5, CCL22 and CXCL8
are known to play a role in the migration of Tregs into inﬂamed
or tumour tissues.14–16 Others, including CCL2-5, CCL20
CCL22, CXCL1-3, CXCL8 and CXCL10 are upregulated in the
H pylori-infected gastric mucosa,5 17–20 and expression of che-
mokine receptors and other adhesion molecules by immune
cells is also increased.10 21 22 Our ﬁrst step was to narrow down
this array of homing molecules and receptors to those that
might be important in Treg migration to the H pylori-infected
gastric mucosa.
We began this study by quantifying chemokines in gastric
biopsy lysates and found that IL-8, CCL20 and CXCL1-3 con-
centrations were the most upregulated in biopsy samples from
infected compared with uninfected patients. We then went on
to screen peripheral blood Tregs for a panel of homing recep-
tors. We identiﬁed altered proﬁles of the chemokine receptors
CCR6, CXCR1 and CXCR2 on Tregs from infected patients.
Next, we deﬁned the signalling pathways involved in
H pylori-mediated induction of CCL20 expression by gastric
epithelial cell lines. Finally, we showed that Tregs from infected
mice can migrate towards CCL20 in vitro. These ﬁndings show
that Tregs can be recruited by the gastric mucosal chemokine
response to H pylori. This mechanism of Treg recruitment may
be important for controlling inﬂammation and reducing cancer
risk among people infected with H pylori.
MATERIALS AND METHODS
Reagents and chemicals were obtained from Sigma-Aldrich
(Poole, UK) and ﬂuorochrome-conjugated antibodies were
obtained from BioLegend (San Diego, USA), unless otherwise
stated.
Participants and clinical materials
Samples were donated by 180 patients (aged 18–86 years)
undergoing routine upper gastrointestinal endoscopy at Queen’s
Medical Centre, Nottingham, UK (collected 2002–2012) after
approval by the Nottingham Research Ethics Committee 2 from
an unselected patient group, for whom H pylori status could be
conﬁrmed and the appropriate clinical materials were available.
Patients presented with a variety of indications, most commonly
dyspepsia, but were otherwise healthy. None of the patients
were regularly taking non-steroidal anti-inﬂammatory drugs or
other immunomodulatory drugs in the preceding 4 weeks, or
antibiotics or proton pump inhibitor drugs during the preceding
2 weeks.
Blood samples and a series of eight gastric antral biopsy
samples were collected with informed written consent.9
Complete sets of blood and biopsy samples were not available
for all subjects. H pylori status was determined by rapid biopsy
urease test, bacterial culture and histology. H pylori isolates
were cagA genotyped as previously described.23 Clinical endos-
copy observations were recorded. Uninfected donors had no
gastric inﬂammation or disease.
Luminex immunoassays
Chemokine concentrations were measured by Luminex (see
online supplementary methods) in antral gastric biopsy samples
from 84 H pylori-infected donors (31 duodenal ulcer, 5 gastric
ulcer, 48 without ulceration) and 39 uninfected donors and nor-
malised for total protein.24 These groups were 52% and 46%
male, respectively; mean ages 53.5 and 54.0 years.
Cell isolation and analysis by ﬂow cytometry
Samples from 35 H pylori-infected donors (10 duodenal ulcer,
1 gastric ulcer, 24 without ulceration) and 46 uninfected donors
were analysed by ﬂow cytometry. These groups were 64% and
52% male, respectively; mean ages 51.0 and 53.6 years.
Six gastric biopsy samples were collected into culture medium
(RPMI 1640/10% fetal calf serum/100 U/mL penicillin
G/100 μg/mL streptomycin sulfate), rubbed through a sterile dis-
posable 100 μm cell strainer (BD Biosciences, Oxford, UK),
washed and resuspended at 1×106/mL.9 Peripheral blood
mononuclear cells (PBMCs) were puriﬁed by density gradient
centrifugation using Histopaque-1077 and resuspended at
1×106/mL.
Extracellular staining using anti-CD4-phycoerythrin (PE)-Texas
Red (ECD; Beckman Coulter, High Wycombe, UK) and
anti-CD25-PE-cyanin 7 (Pc7) with anti-CD127-PE, anti-CD62L-
PE (eBioscience, San Diego, USA), anti-integrin αE-PE
(eBioscience), anti-CCR10-PE, anti-CXCR1-PE or anti-intergrin
β7-PE (eBioscience) and anti-CCR6-Alexa Fluor 647 (A647),
anti-CCR7-A647, anti-CCR9-A647 or anti-CXCR2-A647 was
carried out before cells were ﬁxed in 0.5% formaldehyde. FOXP3
Perm buffer set (BioLegend) permeabilised cells were stained with
anti-FOXP3-Alexa Fluor 488 (A488). Data on 200 000 events
were acquired using a Beckman Coulter Cytomics FC500 and ana-
lysed with Weasel V.3.0, using appropriate isotype controls.
Cell lines and bacterial strains
The human gastric epithelial MKN28 and AGS (ATCC
CRL-1739) cell lines were maintained in RPMI 1640 and nutri-
ent mixture F12 Ham medium, respectively, supplemented with
10% heat inactivated fetal calf serum and 2 mM L-glutamine
(Invitrogen) at 37°C in a 5% CO2 humidiﬁed atmosphere.
H pylori strains were cultured on Blood Agar Base No 2 con-
taining 5% (vol/vol) horse blood (Oxoid, Cambridge, UK) at 37°C
under microaerobic conditions. cagPAI+ H pylori strains 60190,
84183,25 26695, B128 7.13 and the cagPAI− strains SS126 and
Tx30a25 were used, along with isogenic mutants deﬁcient in vacA
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(60190ΔvacA, 84183ΔvacA), cagA (60190ΔcagA, 84183ΔcagA)
and cagE (60190ΔcagE, 84183ΔcagE). A slt (HP0645) deletion
mutant (26695Δslt) and 26695 parental strain were kindly
donated by Dr Richard Ferrero, Monash University, Victoria,
Australia.6
In vitro culture experiments
24-Well culture plates were seeded with 5×104 cells/well 24 h
before experiments. An H pylori suspension was added to a
multiplicity of infection (MOI) of ﬁve bacteria for each epithe-
lial cell, and cultures were incubated for a further 24 h. MOIs
were conﬁrmed by viable cell counts. Cell culture supernatants
were aliquoted and frozen at −80°C.
Human CCL20/MIP-3α ELISA (R&D Systems, Abingdon,
UK) and Human IL-8 CytoSet ELISA (Invitrogen, Paisley, UK)
kits were used, with a standard curve on each plate.
Inhibitor studies and siRNA transfections
Epithelial cells were treated with chemical inhibitors or siRNA
duplexes as previously described.27 Speciﬁc chemical inhibitors
—U0126 (10 μM; MEK1 inhibitor), SP600125 (10 μM;
c-Jun-N-terminal kinase (JNK) inhibitor), SB203586 (10 μM;
p38 inhibitor) and 6-amino-4-(4-phenoxyphenylethylamino)
quinazoline (1 μM; NF-κB activation inhibitor)—were added to
the cells for 1 h before and throughout 24 h infection. Control
cells were treated with 50 ng/mL of recombinant tumour necro-
sis factor α (TNFα) (PeproTech, Rocky Hill, USA) to activate
NF-κB.9
Validated siRNA duplexes targeting NFKB1, RELA and
mitogen-activated protein kinase 1 (MAPK1) mRNA using
HiPerfect transfection regent (QIAGEN, Hilden, Germany)
were added to the cells 48 h before 24 h infection. Control cells
received HiPerfect only, non-silencing AllStars Hs Negative
Control siRNA or AllStars Hs Cell Death Control siRNA. Gene
knockdowns were conﬁrmed by western blotting using NF-κB
p50 (Cell Signalling Technology Inc, Massachusetts, USA),
NF-κB p65 (Merck Millipore, Darmstadt, Germany), extracellu-
lar signal-regulated kinase (ERK) (Santa Cruz Biotechnology,
Santa Cruz, USA) and anti-actin antibodies.
Mouse procedures
Animal experiments were approved by the University of
Nottingham animal welfare and ethical review body, under UK
Home Ofﬁce Licence 40/3399. Foxp3-green ﬂuorescent protein
(GFP) C57/BL6 mice ( JAX strain B6.Cg-Foxp3tm2(EGFP)Tch/J)28
were infected by oral gavage on three alternate days with doses
of 1 × 109 H pylori strain B128 7.13 in 100 mL Isosensitest
broth (Oxoid).11 After 3 weeks mice were humanely killed, their
spleens were removed and rubbed through a sterile disposable
100 μm cell strainer. Cells were enriched using an EasySep
Mouse CD4 T cell enrichment kit (StemCell Technologies,
Vancouver, Canada), and sorted into GFP+ and GFP− popula-
tions using a MoFlo XDP ﬂow cytometer (Beckman Coulter).
Infection was conﬁrmed using quantitative culture of stomach
tissue homogenate, as described previously.29 The median col-
onisation density for the infected mice was 1.31×105 colony-
forming units/g (range 0.625–3.88×105) and colonies were con-
ﬁrmed as H pylori by urease tests and Gram staining.
Migration assay
Migration assays were performed using 96-well Transwell plates
with a 5.0 mm polycarbonate membrane (Corning Life Sciences,
Corning, USA).30 Culture medium (150 μL) with or without
500 ng/mL of recombinant mouse CCL20 was placed in the
lower chamber.31 Culture medium (100 μL) containing 1×105
cells was placed in the upper chamber. Each experiment was
performed in triplicate. After 5 h, migrated cells in the lower
chamber were counted. Migration index was calculated by div-
iding the number of migrated cells by the mean migration seen
in the medium-only control wells.
Statistical analysis
Statistical analyses were carried out using Prism 6.00 (GraphPad
Software, California, USA). A two-tailed p value ≤0.05 was
taken as signiﬁcant. In vivo data were displayed in
box-and-whisker plots showing median, IQR and total range,
and compared using Mann–Whitney U tests. In vitro data were
described using means and SDs, and analysed using one-way
analysis of variance with Dunnett’s post hoc test for multiple
comparisons.
RESULTS
CCL20, IL-8 and CXCL1-3 concentrations were greatly
elevated in H pylori-infected gastric biopsy samples
We began by identifying chemokines which were the most upre-
gulated during H pylori infection. The chemokine concentrations
in gastric biopsy samples from infected and uninfected patients
were measured using Luminex assays. Most were upregulated
during infection; however, the greatest increases were in CCL20
(MIP-3α), CXCL1-3 (GROα, β and γ) and CXCL8 (IL-8). The
median concentrations in biopsy samples from infected patients
were 9.5-fold higher for CCL20 (p<0.0001) and 14.8-fold
higher for IL-8 (p<0.0001) compared with those from unin-
fected patients (ﬁgure 1). The chemokines CXCL1-3 are >90%
homologous and this kit could not distinguish between them;
however, we observed that their combined median concentra-
tions were 6.1-fold higher (p<0.0001) in infected patients.
Other chemokines were increased by only 1.7–3.1-fold.
Peripheral blood Treg homing receptor proﬁles are altered
in H pylori-infected patients
Having identiﬁed the chemokines most upregulated during
infection, we examined homing receptor expression proﬁles on
Figure 1 Analysis of gastric chemokine levels from Helicobacter
pylori-infected and uninfected patients. Gastric biopsy samples from 84
H pylori-infected and 38 uninfected patients were disrupted and
cytokine levels were determined using Luminex. CCL2 (MCP-1), CCL3
(MIP-1α), CCL4 (MIP-1β), CCL5 (RANTES), CCL11 (Eotaxin), CCL20
(MIP-3α), CCL22 (MDC), homologous cytokines CXCL1-3 (GROα, β and
γ), CXCL8 (IL-8) and CXCL10 (IP-10) concentrations were corrected for
the total protein content and plotted on a log10 scale. p Values denote
signiﬁcantly higher concentrations in biopsies from H pylori-infected
patients than in samples from uninfected patients, NS, non-signiﬁcant.
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circulating Tregs and whether these were altered in infected
patients. We hypothesised that differences in peripheral blood
Treg homing receptor proﬁles in the infected patients might
indicate receptors which contribute to Treg migration to the
infected gastric mucosa.
PBMCs from 18 H pylori-infected and 20 uninfected patients
were analysed using ﬂow cytometry. Gating on lymphocytes
from forward and side scatter plots, Tregs were deﬁned as
CD4+CD25hi events. The CD25hi gate was set corresponding to
the position of CD127lo and FOXP3+ events (ﬁgure 2A,B).
Using these gating criteria, the proportion of CD4+CD25hi
events among the lymphocyte population was signiﬁcantly
higher in the H pylori-infected patients (p=0.02) (ﬁgure 2C).
PBMCs were then analysed for a panel of homing receptors
using ﬂow cytometry (ﬁgure 3). The proportion of
CD4+CD25hi events expressing each homing receptor varied
widely (ﬁgure 3C). When examining cells from all patients
together, a median of 94% of the CD4+CD25hi events
expressed CD62L, 57% were CCR6+ and 34% CCR10+. Less
than 10% expressed CCR7, CCR9, CXCR1, CXCR2 or integ-
rins αE and β7. Some receptors varied according to H pylori
status. Compared with uninfected patients, a signiﬁcantly higher
proportion of CD4+CD25hi events from infected patients were
CCR6+ (medians: 46.7% and 63.2% respectively, p=0.034),
CXCR1+ (medians: 0.7% and 9.8%, p=0.040) and CXCR2+
medians: 0.2% and 4.0%, p=0.040). Given these results we
concentrated further investigations on the role of CCR6
(CCL20 receptor), CXCR1 and CXCR2 (IL-8 and CXCL1-3
receptors).
Most gastric mucosal Tregs express CCR6 and many express
IL-8 receptors
We next examined if CCR6, CXCR1 and CXCR2 were also
present on gastric Tregs. Gastric biopsy lymphocytes from 18
infected and 26 uninfected patients were stained for CCR6,
CXCR1 and CXCR2 and analysed using ﬂow cytometry
(ﬁgure 3D). Over 90% of the CD4+CD25hi events from gastric
biopsy samples expressed CCR6, regardless of H pylori status.
The proportions of CD4+CD25hi cells expressing CXCR1 and
CXCR2 were also higher in the gastric biopsy samples than the
PBMCs (72.6% and 57.8%, respectively), but there was no sig-
niﬁcant difference between the infected and uninfected patients.
The total number of CD4+CD25hi and CD4+CD25hiCCR6+
events in biopsies from each patient was calculated (ﬁgure 3E).
As previously described the number of CD4+CD25hi events was
increased in infected patients (median 4921) compared with
uninfected patients (median 1025; p=0.014). Biopsy samples
from H pylori-infected patients also contained signiﬁcantly
increased numbers of CD4+CD25hiCCR6+ events (medians
837.5 and 4754, respectively; p=0.021). These results show
that Tregs in the gastric compartment are enriched for those
expressing CCR6, CXCR1 and CXCR2, and suggest that they
may direct Treg homing to the mucosa.
H pylori-induced CCL20 and IL-8 expression by gastric
epithelial cell lines is cagT4SS dependent
Next, we used two human gastric epithelial cell lines to examine
the role of H pylori virulence factors in inducing the CCL20
response in vitro. We also examined IL-8 which, unlike
CXCL1-3, is a T cell chemoattractant, and has been shown to
be predominantly induced by the cagT4SS.6 Our biopsy data
suggest that CCL20 induction may also be dependent on the
cagT4SS; therefore IL-8 responses were measured as a control.
MKN28 and AGS cells were infected with H pylori at a MOI of
ﬁve bacteria per cell for 24 h before assaying CCL20 and IL-8
production. Compared with uninfected AGS cells, CCL20 con-
centrations were signiﬁcantly increased by co-culture with
strains 60190 (3.8-fold, p=0.005), 84183 (7.5-fold, p<0.001),
26695 (11.2-fold p<0.0001) and B128 (3.3-fold, p=0.011)
(ﬁgure 4A). These strains all have an intact cagPAI and express
the active s1/m1 form of VacA. In contrast, Tx30a
(cagPAI-negative, s2/m2 vacA) and SS1 (defective cagPAI, s2/m2
vacA) did not signiﬁcantly stimulate CCL20 production above
the level of uninfected controls, but induced low-level IL-8
expression (ﬁgure 4B).
Figure 2 Proportion of CD4+CD25hi cells in the peripheral blood of
Helicobacter pylori-infected and uninfected control patients. Peripheral
blood mononuclear cells (PBMCs) from 18 H pylori-infected and 20
uninfected patients were isolated, stained and analysed using ﬂow
cytometry. Cells were stained with CD4-ECD, CD25-Pc7, CD127-PE and
FOXP3-A488 ﬂuorochrome-conjugated monoclonal antibodies. Example
plots show CD4+ gated PBMCs from one H pylori-infected donor
demonstrating reproducible CD25hi gating criteria based on (A) FOXP3+
and (B) CD127lo events. Isotype controls for A488 and PE are shown.
(C) The proportion of CD4+CD25hi lymphocytes was compared for
infected and uninfected patients.
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Cell lines were then co-cultured with isogenic mutants derived
from multiple parental stains of H pylori, null for candidate
cagPAI genes and vacA. Their effects on CCL20 and IL-8 were
similar, but more pronounced in MKN28 than AGS cells (ﬁgure
4). The ΔcagA mutants induced less CCL20 than their wild-type
parental strains but this was only signiﬁcant for MKN28 cells
(60190ΔcagA:1.4-fold lower, p=0.039; 84183ΔcagA: 1.5-fold,
p=0.022). However, deletion of the cagE gene, resulting in a dis-
abled T4SS, led to CCL20 concentrations similar to those of
uninfected controls for both cell lines (compared with wild-type
for AGS cells, 60190ΔcagE: 9.9-fold lower, p=0.031;
84183ΔcagE: 3.3-fold lower, p=0.001). Disruption of vacA did
not alter the levels of CCL20 production. These data suggest that
the cagT4SS is necessary for H pylori-induction of CCL20, but
this is only partially dependent on CagA delivery.
The cagPAI also induces IL-8 via peptidoglycan activation of
NOD1. To determine if this mechanism is also important in
CCL20 induction, cells were cultured with an slt null mutant
(26695Δslt). This mutant has comparable growth rates to its
parental strain, but produces up to 40% less cell wall disacchar-
ide tripeptide owing to a defect in the slt-encoded lytic transgly-
cosylase.6 32 The 26695Δslt mutant stimulated 9.9-fold
(p<0.0001) and 19.1-fold (p=0.0004) lower CCL20 concen-
trations than the wild-type by MKN28 and AGS cells respect-
ively (ﬁgure 4A,C). A similar decrease in IL-8 was also seen, in
line with previous reports.6 25 These results show that CCL20
expression is induced by H pylori in a cagT4SS-dependent
manner, largely via CagA-independent signalling. In agreement
with this, gastric biopsy samples from patients infected with
cagA+ strains contained higher CCL20 concentrations
Figure 3 Expression of homing
receptors on CD4+CD25hi events. Cells
were isolated and stained for Treg
markers and homing receptors.
Example plots show CD4+ events with
the gating used for (A) CCR6-A647
and CXCR2-A647 and (B) CXCR1-PE
staining. The proportion of
CD4+CD25hi events expressing each
receptor was determined using ﬂow
cytometry. (C) Peripheral blood
mononuclear cells were analysed from
18 Helicobacter pylori-infected and 20
uninfected patients and (D) gastric
biopsy samples from 18 H pylori-
infected and 26 uninfected patients
were analysed. (E) In addition, the
total numbers of CD4+CD25hiCCR6+
events isolated from gastric biopsy
samples were calculated. p Values
denote statistically signiﬁcant
differences.
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(p=0.021) than those infected with a cagA− strain (see online
supplementary ﬁgure S1).
The NF-κB and MAPK1-pathways are important in
H pylori-induced CCL20 expression
We investigated the role of NF-κB and the ERK, p38 and JNK
MAP kinase signalling pathways, known to be activated by the
cagT4SS.4 MKN28 cells were cultured with H pylori strain
60190 in the presence of speciﬁc drug inhibitors for each
pathway and the effects on CCL20 and IL-8 production were
assessed (ﬁgure 5). NF-κB and MEK1 inhibitors signiﬁcantly
reduced induction of CCL20 compared with untreated control
wells (10-fold, p=0.0001 and sixfold, p=0.0005, respectively),
whereas the effect of the p38 inhibitor did not reach statistical
signiﬁcance. JNK inhibition appeared to increase CCL20
expression (1.9-fold, p=0.0001). Uninfected cells were treated
with recombinant TNFα as a positive control activator of
NF-κB, which increased CCL20 expression (threefold,
p=0.018). The treatments had very similar effects on IL-8
expression. These results conﬁrm the importance of NF-κB and
suggest the MAPK1 pathways may also have a signiﬁcant role in
H pylori-induction of CCL20.
To investigate these mechanisms more precisely, MKN28 cells
were treated with siRNA duplexes to silence expression of
NFKB1 (which encodes the NF-κBp50 subunit), RELA
(NF-κBp65) and MAPK1 for 48 h before infection with 60190
H pylori (ﬁgure 6A,B). In agreement with the previous data,
greatly reduced CCL20 concentrations were seen in infected
cells where RELA (11-fold, p<0.001) and MAPK1 (108-fold,
p<0.001) expression was knocked down (ﬁgure 6B). These
duplexes had similar effects on IL-8 expression (ﬁgure 6C), sug-
gesting that IL-8 and CCL20 are induced by the same pathways.
Mouse Tregs migrate towards CCL20
To investigate whether CCL20 is a chemoattractant for Tregs,
we used Foxp3-GFP transgenic mice as this provides the most
reliable means of Treg cell puriﬁcation. Mice were infected with
the cagPAI+ H pylori strain B128, and killed 3 weeks later. As
expected there were higher frequencies of CD4+Foxp3+ events
in gastric mucosa of infected mice (medians of 0.44% of CD3+
events for uninfected and 1.75% for infected, p=0.002). GFP+
and GFP− CD4+ splenocytes were isolated from infected mice
(ﬁgure 7A). Flow cytometry analysis showed that 9.5% of the
GFP+ Foxp3+ population expressed CCR6, compared with
only 0.71% of the GFP− Foxp3− cells (ﬁgure 7B). Migration of
these populations towards 500 ng/mL recombinant murine
CCL20 (rCCL20) was assessed using an in vitro transwell assay
(ﬁgure 7C). Foxp3− cells did not migrate; however, the Foxp3+
population showed signiﬁcant migration (p=0.006). This is
probably due to the increased proportion of CCR6+ events
amongst Foxp3+ cells.
DISCUSSION
We found that Tregs in human gastric biopsy samples are pre-
dominantly CCR6+, which allows them to respond to
cagT4SS-induced CCL20 expression during H pylori infection.
This paper provides a number of new ﬁndings. For the ﬁrst
time we have described changes in the proﬁles of chemokine
receptors expressed by circulating Tregs from H pylori-infected
patients compared with uninfected patients. The association
between H pylori and increased proportions of CCR6+,
CXCR1+ and CXCR2+ Tregs in the bloodstream allowed us to
target these receptors and their chemokine ligands in subsequent
experiments. Previous work has concentrated on characterising
the expression of homing receptors on gastric T cells during
H pylori-induced disease.19–21 Indeed, we found that Tregs
Figure 4 The effect of bacterial virulence factors on chemokine expression in vitro. AGS (A,B) and MKN28 cells (C,D) were co-cultured with
cag-deﬁcient Helicobacter pylori strains Tx30a, SS1 or mutant series constructed in cag-positive strains B128, 60190, 84183 and 26695 (MOI=5).
After 24 h, CCL20 (A,C) and IL-8 (B,D) concentrations in culture supernatants were measured by ELISA. Graphs show means and SDs from three
independent experiments, each performed in triplicate. p Values display signiﬁcant differences compared with parental strains. MOI, multiplicity of
infection.
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isolated from the gastric mucosa are predominantly CCR6+.
However, characterising the peripheral Treg response to infec-
tion provides two advantages: ﬁrst, obtaining blood samples
from patients is less invasive than endoscopy, giving greater
potential for larger study groups; and second, more Tregs can
be recovered, allowing more detailed characterisation using mul-
tiple markers.
The intriguing ﬁnding that more CD4+CD25hicells express
CCR6 in the peripheral blood of H pylori-infected patients led
us to investigate its ligand, CCL20. We demonstrated that
CCL20 levels were increased in the gastric mucosa of
H pylori-infected patients, in keeping with previous ﬁnd-
ings.20 33 However, we also showed for the ﬁrst time that
CCL20 concentrations were increased in the infected gastric
mucosa by a similar degree to the widely studied chemokine
IL-8, and CCL20 levels were much higher. The other chemo-
kines were almost all present at higher concentrations in
infected tissue, but their levels were increased threefold at most.
This highlights the importance of CCL20 in the mucosal
response to H pylori. The high basal levels of CCL20 in the
gastric mucosa goes some way to explain why, even in unin-
fected patients, most gastric Tregs express CCR6. Surprisingly,
almost all Tregs isolated from the gastric mucosa expressed
CCR6. However, the number of Tregs inﬁltrating the gastric
Figure 5 Role of signalling pathways in Helicobacter pylori-stimulated
CCL20 secretion by epithelial cells. MKN28 cells were treated before
and during infection with chemical inhibitors for NF-κB, JNK, MEK1 or
p38, or drug diluent alone (see ‘Materials and methods’). Tumour
nercrosis factor α (TNFα) treatment was included as a positive control
NF-κB inducer. (A) CCL20 and (B) IL-8 supernatant levels were
assessed using ELISA. Graph shows means and SDs from four
independent experiments performed in triplicate. p Values denote
signiﬁcantly different concentrations compared with H pylori-infected
controls. JNK, c-Jun-N-terminal kinase.
Figure 6 Helicobacter pylori-dependent expression of CCL20 by
epithelial cells in vitro after siRNA knockdown of signalling pathways.
MKN28 cells were pretreated with siRNA duplexes in HiPerfect
transfection reagent for 48 h. siRNA treatments targeted NF-κBp50
(NFKB1), NF-κBp65 (RELA) and MAPK1 genes. Negative controls were
non-silencing duplexes; positive control duplexes targeted genes
necessary for survival. Cells were then treated with 60190 H pylori for
24 h. (A) Western blot analysis showing knockdown by siRNA
constructs. Supernatant CCL20 (B) and IL-8 (C) levels were then
determined using ELISA. Graphs show means and SD from three
independent experiments performed in triplicate. p Values show
signiﬁcant differences compared with H pylori-infected siRNA negative
controls. MAPK, mitogen-activated protein kinase.
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mucosa is signiﬁcantly increased in H pylori infection9 and here
we show that the number of CCR6+ Tregs in the gastric mucosa
of H pylori infected patients is also signiﬁcantly increased.
We built on previous co-culture experiments which showed
that CCL20 mRNA levels in gastric epithelial cell lines were
reduced in response to a cagPAI-deﬁcient strain,33 to
demonstrate for the ﬁrst time that peptidoglycan components
delivered by the cag T4SS are the major inducers of CCL20 pro-
duction in gastric epithelial cell lines. A number of different
transcription factor binding sites have been described in the
CCL20 gene promoter region, including sites for activator
protein 1 (AP-1) and NF-κB.34 MEK and NF-κB signalling have
been linked to CCL20 induction in response to proinﬂamma-
tory stimuli in other cell types, including colonic epithelial
cells.35 We show that in gastric epithelial cells H pylori peptido-
glycan components activate ERK and NF-κB signalling, thus
inducing CCL20 in a similar way to that already described for
IL-8.6 Previously, the p38 pathway was shown to be important
in activation of IL-8 production in response to H pylori peptido-
glycan.36 Our data conﬁrm that IL-8 is signiﬁcantly reduced in
cells treated with a p38 inhibitor. However, although we
observed that inhibiting the p38 pathway led to a consistent
reduction in CCL20 production across the three independent
experiments performed, this did not reach statistical signiﬁcance
when all data were combined. Therefore, ERK and NF-κB signal-
ling (and possibly also p38) mediate the induction of CCL20 in
response to H pylori peptidoglycan via the cagT4SS, In support
of these ﬁndings, we observed the highest mucosal CCL20 con-
centrations in patients infected with a cagA+ strain of H pylori.
Our results suggest that bacterial strains better equipped to
interact with their host, such as those with an intact cagT4SS,
may more strongly inﬂuence the immunoregulatory response. In
support of this, we previously showed that patients infected
with cagPAI+ H pylori strains had higher levels of IL10 mRNA
and increased inﬁltration of CD4+CD25hi cells in their gastric
mucosa.9 These data may appear to be in conﬂict with the evi-
dence that PUD is more common among individuals infected
with cagPAI+ strains.1 Kido et al37 have suggested that the
cagT4SS has a dual role in H pylori infection, acting to both
promote and suppress gastritis. Using mouse models, they
showed that infection, particularly with a CagA+ H pylori
strain, was important for inducing the migration of T cells
(primed by either CagA+ or CagA− infections) into the gastric
mucosa, resulting in gastritis. Conversely, adoptive transfer of
T cells ﬁrst primed by a CagA+ infection led to an accumulation
of Tregs in the gastric mucosa of recipient mice and gastritis was
attenuated; this did not occur with T cells primed by CagA−
H pylori. Their conclusion that the cagT4SS is extremely
important for the induction of a protective Treg response is also
supported by our ﬁndings. In patients infected with a cagPAI+
strain, high cytokine expression leads to gastritis, and we
propose that the effect of the cagT4SS on Treg migration
becomes more important for controlling this inﬂammation.
Ulcers probably result when there is a deﬁciency in this process.
Treg migration patterns contribute to the tight control of
their anti-inﬂammatory effects and can be altered during an
ongoing response, to target immune suppression.22 38 39 The
altered human Treg homing receptor proﬁles seen here may be
important in controlling the inﬂammatory response to H pylori.
Tregs reduce inﬂammation to avoid excess damage to the host
and, in H pylori infection, inﬂammation drives disease. Looking
at Treg homing might help to identify patients at risk of devel-
oping more extensive disease. CCR6 is also expressed by a
number of other cell types including dendritic cells and B lym-
phocytes,40 which also play important roles in the host response
to H pylori infection. CCR6 is highly expressed on the proin-
ﬂammatory Th17 cell type.30 The balance between Th17 and
Treg cells is thought to be important in determining the severity
of H pylori-mediated gastric inﬂammation.41 Both Th17 and
Tregs preferentially localise to mucosal surfaces through CCL20
Figure 7 Migration of mouse Foxp3+ cells towards recombinant
CCL20. Foxp3-GFP C57/BL6 mice were infected with Helicobacter pylori
strain B128 7.13. After 3 weeks their splenocytes were harvested and
pooled. CD4 enrichment was performed using EasySep separation and
then GFP+ and GFP− populations were sorted using ﬂow cytometry.
The CD4+FoxP3-depleted fraction and CD4+FoxP3-enriched fractions (A)
were stained for CCR6 (B). Numbers at the top right denote the
percentage of double positive events. Migration of these cells towards
recombinant 500 ng/mL of recombinant CCL20 (rCCL20) was assessed
using a 96-well Transwell plate (C). The migration index was calculated
by dividing the number of migrated cells in the lower chamber of each
well, by the average migration seen in the medium-only control wells.
The graph shows means and SDs from three independent experiments
each performed in triplicate. GFP, green ﬂuorescent protein.
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signalling, and the CCL20–CCR6 axis is currently the subject of
a great deal of research in IBD.42 43 Similar to our ﬁndings,
CCL20 expression is elevated in the IBD mucosa, and protec-
tion from colitis has been shown to be mediated by CCR6+
Tregs.44 45 There is growing evidence that H pylori infection is
negatively associated with IBD,46 47 but if this is the case the
mechanism remains unclear. Induction of CCR6+ Tregs by
H pylori may result in their migration towards CCL20
expressed in the stomach and the intestine to modulate inﬂam-
mation. Future work therefore needs to elucidate the role of the
CCL20–CCR6 axis in the H pylori-infected gastric mucosa, and
its possible inﬂuence on IBD.
In summary, we showed that increased proportions of Tregs
express the chemokine receptors CCR6, CXCR1 and CXCR2
in the peripheral blood of H pylori-infected individuals.
However, the majority of gastric Tregs express CCR6. In gastric
biopsy samples CCL20, the only chemokine recognised by
CCR6, is increased in response to H pylori and is more abun-
dant than IL-8. CCL20 expression is induced in gastric epithe-
lial cells in a cagT4SS-dependent manner by H pylori via the
NF-κB and MAPK pathways. Recombinant CCL20 induces
migration of puriﬁed mouse Tregs. We are now developing
mouse model assays to further characterise the role of the
CCL20–CCR6 axis in Treg cell homing in vivo.
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